Literature DB >> 15038598

Neuropathological aspects of mitochondrial DNA disease.

Joanne Betts1, Robert N Lightowlers, Douglass M Turnbull.   

Abstract

Mitochondrial DNA disorders are an important cause of neurological disease, yet despite our awareness of the importance of these conditions, relatively little is known about the neuropathology of these disorders and even less about the mechanisms involved in neuronal dysfunction and death. In this review we detail important features from neuropathological studies available and highlight deficiencies that are currently limiting our understanding of mitochondrial DNA disease. We also discuss possible future approaches that might resolve some of these outstanding issues. Further study of these disorders is critical because mitochondria play a central role in neuronal survival and it is likely that an understanding of the mechanisms involved in neuronal dysfunction and cell death in mitochondrial DNA disease may have implications for other neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038598     DOI: 10.1023/b:nere.0000014821.07269.8d

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  62 in total

Review 1.  Neuronal degeneration and mitochondrial dysfunction.

Authors:  Eric A Schon; Giovanni Manfredi
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 2.  The neurology of mitochondrial DNA disease.

Authors:  Robert McFarland; Robert W Taylor; Douglass M Turnbull
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

3.  Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  H Hasegawa; T Matsuoka; Y Goto; I Nonaka
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

4.  Involvement of choroid plexus in mitochondrial encephalomyopathy (MELAS).

Authors:  E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy.

Authors:  J M Clark; M P Marks; E Adalsteinsson; D M Spielman; D Shuster; D Horoupian; G W Albers
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

Review 7.  Status spongiosus of nervous tissue. Electron microscopic studies.

Authors:  B Adornato; P Lampert
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

8.  Vascular involvement in mitochondrial myopathy.

Authors:  R Sakuta; I Nonaka
Journal:  Ann Neurol       Date:  1989-06       Impact factor: 10.422

9.  Increased mitochondrial DNA in blood vessels and ragged-red fibers in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  M Tokunaga; S Mita; R Sakuta; I Nonaka; S Araki
Journal:  Ann Neurol       Date:  1993-03       Impact factor: 10.422

10.  Mitochondrial encephalomyopathies: a correlation between neuropathological findings and defects in mitochondrial DNA.

Authors:  P A McKelvie; J B Morley; E Byrne; S Marzuki
Journal:  J Neurol Sci       Date:  1991-03       Impact factor: 3.181

View more
  19 in total

Review 1.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

Review 2.  The neurodegenerative mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.

Authors:  Paul T Kotzbauer; Adam C Truax; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

4.  Additive effects of mitochondrion-targeted cytochrome CYP2E1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes.

Authors:  Seema Bansal; Satish Srinivasan; Sureshkumar Anandasadagopan; Anindya Roy Chowdhury; Venkatesh Selvaraj; Balaraman Kalyanaraman; Joy Joseph; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 5.  Bioenergetic medicine.

Authors:  Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 6.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

7.  Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations.

Authors:  Andrey Y Abramov; Tora K Smulders-Srinivasan; Denise M Kirby; Rebeca Acin-Perez; José Antonio Enriquez; Robert N Lightowlers; Michael R Duchen; Douglass M Turnbull
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

Review 8.  Estrogen actions on mitochondria--physiological and pathological implications.

Authors:  James W Simpkins; Shao-Hua Yang; Saumyendra N Sarkar; Virginia Pearce
Journal:  Mol Cell Endocrinol       Date:  2008-05-02       Impact factor: 4.102

9.  Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions.

Authors:  Andreas Bender; Rachel-Maria Schwarzkopf; Anja McMillan; Kim J Krishnan; Gabriele Rieder; Manuela Neumann; Matthias Elstner; Douglas M Turnbull; Thomas Klopstock
Journal:  J Neurol       Date:  2008-07-11       Impact factor: 4.849

10.  Disruption of mitochondrial DNA replication in Drosophila increases mitochondrial fast axonal transport in vivo.

Authors:  Rehan M Baqri; Brittany A Turner; Mary B Rheuben; Bradley D Hammond; Laurie S Kaguni; Kyle E Miller
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.